Phase III Vaccine Trial in Africa Gives Poor Results about New Malaria Drug

mosquito-malaria

A phase III clinical trial in Africa of the RTS,S/AS01 malaria vaccine has reported disappointing results. The vaccine failed to show substantial protection for infants who received their first shot between 6 and 12 weeks of age.

Read more @ SciTechDaily

Author: range

I'm mathematician/IT strategist/blogger from Canada living in Taipei.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s